Search results
1 company and 2 research reports found for "Curis"
Company results
- Curis
Curis is a US drug development company focusing on disruption of signalling pathways in oncology. Th...
Sector reports
No sector reports have been found.
Research results
Curis
Vismodegib approved
QuickView | Pharmaceutical & Healthcare | 31/01/2012Curis has earned a $10m milestone from Genentech (Roche), following the FDA’s approval yesterday of Erivedge (vismodegib) for advanced inoperabl...
Curis
Vismo NDA accepted
QuickView | Pharmaceutical & Healthcare | 11/11/2011The US FDA’s acceptance for review of Roche’s vismodegib NDA for the treatment of advanced inoperable basal cell carcinoma should substant...
